30-Day morbidity and mortality of bariatric metabolic surgeryin adolescence during the COVID-19 pandemic–the Geneva study
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRN |
Texto Completo: | https://repositorio.ufrn.br/handle/123456789/53202 https://doi.org/10.1111/ijpo.12832 |
Resumo: | Background Metabolic and bariatric surgery (MBS) is an effective treatment for adolescents with severe obesity. Objectives This study examined the safety of MBS in adolescents during the coronavirus disease 2019 (COVID-19) pandemic. Methods This was a global, multicentre and observational cohort study of MBS performed between May 01, 2020, and October 10,2020, in 68 centres from 24 countries. Data collection included in-hospital and 30-day COVID-19 and surgery-specific morbidity/mortality. Results One hundred and seventy adolescent patients (mean age: 17.75 ± 1.30 years), mostly females (n = 122, 71.8%), underwent MBS during the study period. The mean pre-operative weight and body mass index were 122.16 ± 15.92 kg and 43.7 ± 7.11 kg/m2, respectively. Although majority of patients had pre-operative testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (n = 146; 85.9%), only 42.4% (n = 72) of the patients were asked to self-isolate pre-operatively. Two patients developed symptomatic SARS-CoV-2 infection post-operatively (1.2%). The overall complication rate was 5.3% (n = 9). There was no mortality in this cohort. Conclusions MBS in adolescents with obesity is safe during the COVID-19 pandemic when performed within the context of local precautionary procedures (such as pre-operative testing). The 30-day morbidity rates were similar to those reported pre-pandemic. These data will help facilitate the safe re-introduction of MBS services for this group of patients. |
id |
UFRN_d14230733368b8c4020572d2de1da12b |
---|---|
oai_identifier_str |
oai:https://repositorio.ufrn.br:123456789/53202 |
network_acronym_str |
UFRN |
network_name_str |
Repositório Institucional da UFRN |
repository_id_str |
|
spelling |
Quinino, Reynaldo Martins eSinghal, RishiWiggins, Tomet alhttps://orcid.org/0000-0002-4284-25432023-07-10T19:59:24Z2023-07-10T19:59:24Z2021-06-14QUININO, Reynaldo Martins e, et al. 30‐Day morbidity and mortality of bariatric metabolic surgery in adolescence during the COVID ‐19 pandemic – The GENEVA study. Pediatric Obesity, [S.L.], v. 16, n. 12, p. 1, 8 jul. 2021. Wiley. http://dx.doi.org/10.1111/ijpo.12832. Disponível em: https://onlinelibrary.wiley.com/doi/10.1111/ijpo.12832. Acesso em: 10 jul. 2023.https://repositorio.ufrn.br/handle/123456789/53202https://doi.org/10.1111/ijpo.12832WileyAttribution-NonCommercial-NoDerivs 3.0 Brazilhttp://creativecommons.org/licenses/by-nc-nd/3.0/br/info:eu-repo/semantics/openAccessbariatric surgeryCOVID-19pandemicSARS-CoV-230-Day morbidity and mortality of bariatric metabolic surgeryin adolescence during the COVID-19 pandemic–the Geneva studyinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleBackground Metabolic and bariatric surgery (MBS) is an effective treatment for adolescents with severe obesity. Objectives This study examined the safety of MBS in adolescents during the coronavirus disease 2019 (COVID-19) pandemic. Methods This was a global, multicentre and observational cohort study of MBS performed between May 01, 2020, and October 10,2020, in 68 centres from 24 countries. Data collection included in-hospital and 30-day COVID-19 and surgery-specific morbidity/mortality. Results One hundred and seventy adolescent patients (mean age: 17.75 ± 1.30 years), mostly females (n = 122, 71.8%), underwent MBS during the study period. The mean pre-operative weight and body mass index were 122.16 ± 15.92 kg and 43.7 ± 7.11 kg/m2, respectively. Although majority of patients had pre-operative testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (n = 146; 85.9%), only 42.4% (n = 72) of the patients were asked to self-isolate pre-operatively. Two patients developed symptomatic SARS-CoV-2 infection post-operatively (1.2%). The overall complication rate was 5.3% (n = 9). There was no mortality in this cohort. Conclusions MBS in adolescents with obesity is safe during the COVID-19 pandemic when performed within the context of local precautionary procedures (such as pre-operative testing). The 30-day morbidity rates were similar to those reported pre-pandemic. These data will help facilitate the safe re-introduction of MBS services for this group of patients.engreponame:Repositório Institucional da UFRNinstname:Universidade Federal do Rio Grande do Norte (UFRN)instacron:UFRNORIGINAL30DayMorbidityBariatricMetabolic_Quinino_2021.pdf30DayMorbidityBariatricMetabolic_Quinino_2021.pdfapplication/pdf1462585https://repositorio.ufrn.br/bitstream/123456789/53202/1/30DayMorbidityBariatricMetabolic_Quinino_2021.pdfe958edf3b15f7d7a0a26eba2b782a230MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8811https://repositorio.ufrn.br/bitstream/123456789/53202/2/license_rdfe39d27027a6cc9cb039ad269a5db8e34MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81484https://repositorio.ufrn.br/bitstream/123456789/53202/3/license.txte9597aa2854d128fd968be5edc8a28d9MD53123456789/532022023-07-10 17:05:34.257oai:https://repositorio.ufrn.br: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Repositório de PublicaçõesPUBhttp://repositorio.ufrn.br/oai/opendoar:2023-07-10T20:05:34Repositório Institucional da UFRN - Universidade Federal do Rio Grande do Norte (UFRN)false |
dc.title.pt_BR.fl_str_mv |
30-Day morbidity and mortality of bariatric metabolic surgeryin adolescence during the COVID-19 pandemic–the Geneva study |
title |
30-Day morbidity and mortality of bariatric metabolic surgeryin adolescence during the COVID-19 pandemic–the Geneva study |
spellingShingle |
30-Day morbidity and mortality of bariatric metabolic surgeryin adolescence during the COVID-19 pandemic–the Geneva study Quinino, Reynaldo Martins e bariatric surgery COVID-19 pandemic SARS-CoV-2 |
title_short |
30-Day morbidity and mortality of bariatric metabolic surgeryin adolescence during the COVID-19 pandemic–the Geneva study |
title_full |
30-Day morbidity and mortality of bariatric metabolic surgeryin adolescence during the COVID-19 pandemic–the Geneva study |
title_fullStr |
30-Day morbidity and mortality of bariatric metabolic surgeryin adolescence during the COVID-19 pandemic–the Geneva study |
title_full_unstemmed |
30-Day morbidity and mortality of bariatric metabolic surgeryin adolescence during the COVID-19 pandemic–the Geneva study |
title_sort |
30-Day morbidity and mortality of bariatric metabolic surgeryin adolescence during the COVID-19 pandemic–the Geneva study |
author |
Quinino, Reynaldo Martins e |
author_facet |
Quinino, Reynaldo Martins e Singhal, Rishi Wiggins, Tom et al |
author_role |
author |
author2 |
Singhal, Rishi Wiggins, Tom et al |
author2_role |
author author author |
dc.contributor.authorID.pt_BR.fl_str_mv |
https://orcid.org/0000-0002-4284-2543 |
dc.contributor.author.fl_str_mv |
Quinino, Reynaldo Martins e Singhal, Rishi Wiggins, Tom et al |
dc.subject.por.fl_str_mv |
bariatric surgery COVID-19 pandemic SARS-CoV-2 |
topic |
bariatric surgery COVID-19 pandemic SARS-CoV-2 |
description |
Background Metabolic and bariatric surgery (MBS) is an effective treatment for adolescents with severe obesity. Objectives This study examined the safety of MBS in adolescents during the coronavirus disease 2019 (COVID-19) pandemic. Methods This was a global, multicentre and observational cohort study of MBS performed between May 01, 2020, and October 10,2020, in 68 centres from 24 countries. Data collection included in-hospital and 30-day COVID-19 and surgery-specific morbidity/mortality. Results One hundred and seventy adolescent patients (mean age: 17.75 ± 1.30 years), mostly females (n = 122, 71.8%), underwent MBS during the study period. The mean pre-operative weight and body mass index were 122.16 ± 15.92 kg and 43.7 ± 7.11 kg/m2, respectively. Although majority of patients had pre-operative testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (n = 146; 85.9%), only 42.4% (n = 72) of the patients were asked to self-isolate pre-operatively. Two patients developed symptomatic SARS-CoV-2 infection post-operatively (1.2%). The overall complication rate was 5.3% (n = 9). There was no mortality in this cohort. Conclusions MBS in adolescents with obesity is safe during the COVID-19 pandemic when performed within the context of local precautionary procedures (such as pre-operative testing). The 30-day morbidity rates were similar to those reported pre-pandemic. These data will help facilitate the safe re-introduction of MBS services for this group of patients. |
publishDate |
2021 |
dc.date.issued.fl_str_mv |
2021-06-14 |
dc.date.accessioned.fl_str_mv |
2023-07-10T19:59:24Z |
dc.date.available.fl_str_mv |
2023-07-10T19:59:24Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
QUININO, Reynaldo Martins e, et al. 30‐Day morbidity and mortality of bariatric metabolic surgery in adolescence during the COVID ‐19 pandemic – The GENEVA study. Pediatric Obesity, [S.L.], v. 16, n. 12, p. 1, 8 jul. 2021. Wiley. http://dx.doi.org/10.1111/ijpo.12832. Disponível em: https://onlinelibrary.wiley.com/doi/10.1111/ijpo.12832. Acesso em: 10 jul. 2023. |
dc.identifier.uri.fl_str_mv |
https://repositorio.ufrn.br/handle/123456789/53202 |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1111/ijpo.12832 |
identifier_str_mv |
QUININO, Reynaldo Martins e, et al. 30‐Day morbidity and mortality of bariatric metabolic surgery in adolescence during the COVID ‐19 pandemic – The GENEVA study. Pediatric Obesity, [S.L.], v. 16, n. 12, p. 1, 8 jul. 2021. Wiley. http://dx.doi.org/10.1111/ijpo.12832. Disponível em: https://onlinelibrary.wiley.com/doi/10.1111/ijpo.12832. Acesso em: 10 jul. 2023. |
url |
https://repositorio.ufrn.br/handle/123456789/53202 https://doi.org/10.1111/ijpo.12832 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
Attribution-NonCommercial-NoDerivs 3.0 Brazil http://creativecommons.org/licenses/by-nc-nd/3.0/br/ info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Attribution-NonCommercial-NoDerivs 3.0 Brazil http://creativecommons.org/licenses/by-nc-nd/3.0/br/ |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Wiley |
publisher.none.fl_str_mv |
Wiley |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRN instname:Universidade Federal do Rio Grande do Norte (UFRN) instacron:UFRN |
instname_str |
Universidade Federal do Rio Grande do Norte (UFRN) |
instacron_str |
UFRN |
institution |
UFRN |
reponame_str |
Repositório Institucional da UFRN |
collection |
Repositório Institucional da UFRN |
bitstream.url.fl_str_mv |
https://repositorio.ufrn.br/bitstream/123456789/53202/1/30DayMorbidityBariatricMetabolic_Quinino_2021.pdf https://repositorio.ufrn.br/bitstream/123456789/53202/2/license_rdf https://repositorio.ufrn.br/bitstream/123456789/53202/3/license.txt |
bitstream.checksum.fl_str_mv |
e958edf3b15f7d7a0a26eba2b782a230 e39d27027a6cc9cb039ad269a5db8e34 e9597aa2854d128fd968be5edc8a28d9 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRN - Universidade Federal do Rio Grande do Norte (UFRN) |
repository.mail.fl_str_mv |
|
_version_ |
1802117544333541376 |